» Articles » PMID: 30658691

Antiviral Activity of Itraconazole Against Type I Feline Coronavirus Infection

Overview
Journal Vet Res
Publisher Biomed Central
Date 2019 Jan 20
PMID 30658691
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Feline coronaviruses (FCoVs) are the causative agents of severe systemic disease (feline infectious peritonitis: FIP) in domestic and wild cats. FCoVs have been classified into serotypes I and II. Type I FCoV is the dominant serotype (approximately 70-90%) worldwide. Therefore, it is necessary to provide antiviral agents for type I FCoV infection. In this study, we demonstrated that itraconazole (ICZ), practically used for fungal infections in cats, inhibits the type I FCoV infection. ICZ also exhibited antiviral effect in cells after viral infection, suggesting that ICZ could potentially be used as a therapeutic.

Citing Articles

In Vitro Evaluation of Aryl Hydrocarbon Receptor Involvement in Feline Coronavirus Infection.

Del Sorbo L, Giugliano R, Cerracchio C, Iovane V, Salvatore M, Serra F Viruses. 2025; 17(2).

PMID: 40006982 PMC: 11860311. DOI: 10.3390/v17020227.


Feline infectious peritonitis: A comprehensive evaluation of clinical manifestations, laboratory diagnosis, and therapeutic approaches.

Moyadee W, Sunpongsri S, Choowongkomon K, Roytrakul S, Rattanasrisomporn A, Tansakul N J Adv Vet Anim Res. 2024; 11(1):19-26.

PMID: 38680809 PMC: 11055576. DOI: 10.5455/javar.2024.k742.


Lipid compartments and lipid metabolism as therapeutic targets against coronavirus.

Cesar-Silva D, Pereira-Dutra F, Giannini A, Maya-Monteiro C, de Almeida C Front Immunol. 2023; 14:1268854.

PMID: 38106410 PMC: 10722172. DOI: 10.3389/fimmu.2023.1268854.


Feline Infectious Peritonitis: European Advisory Board on Cat Diseases Guidelines.

Tasker S, Addie D, Egberink H, Hofmann-Lehmann R, Hosie M, Truyen U Viruses. 2023; 15(9).

PMID: 37766254 PMC: 10535984. DOI: 10.3390/v15091847.


Rottlerin-Liposome Inhibits the Endocytosis of Feline Coronavirus Infection.

Choi J, Jung S, Choi I, Kang Y, Lee D, Lee S Vet Sci. 2023; 10(6).

PMID: 37368766 PMC: 10302841. DOI: 10.3390/vetsci10060380.


References
1.
McKinsey D, Wheat L, Cloud G, Pierce M, Black J, Bamberger D . Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis. 1999; 28(5):1049-56. DOI: 10.1086/514744. View

2.
Hohdatsu T, Okada S, Ishizuka Y, Yamada H, Koyama H . The prevalence of types I and II feline coronavirus infections in cats. J Vet Med Sci. 1992; 54(3):557-62. DOI: 10.1292/jvms.54.557. View

3.
Addie D, Schaap I, Nicolson L, Jarrett O . Persistence and transmission of natural type I feline coronavirus infection. J Gen Virol. 2003; 84(Pt 10):2735-2744. DOI: 10.1099/vir.0.19129-0. View

4.
Kummrow M, Meli M, Haessig M, Goenczi E, Poland A, Pedersen N . Feline coronavirus serotypes 1 and 2: seroprevalence and association with disease in Switzerland. Clin Diagn Lab Immunol. 2005; 12(10):1209-15. PMC: 1247821. DOI: 10.1128/CDLI.12.10.1209-1215.2005. View

5.
Hohdatsu T, Sasamoto T, Okada S, Koyama H . Antigenic analysis of feline coronaviruses with monoclonal antibodies (MAbs): preparation of MAbs which discriminate between FIPV strain 79-1146 and FECV strain 79-1683. Vet Microbiol. 1991; 28(1):13-24. PMC: 7117509. DOI: 10.1016/0378-1135(91)90096-x. View